Join us for a support group meeting hosted by Philip, our California Support Group Leader! The meeting will take place at the Long Beach Public Library – Dana Branch in the Community Room. If you are an individual diagnosed or a care partner for someone with ADEM, AFM, MOGAD, NMOSD, ON, or TM, we invite you to join us.
Come connect with others and discuss what it’s like living with a rare neuroimmune disorder. Ask questions, share your stories, or just listen – everyone is welcome.
COVID-19 remains a public health concern. COVID-19 represents a real and significant risk to our community.
– If you are experiencing any signs or symptoms of COVID-like illness, it is in your and everyone’s best interest that you do not attend in person. If necessary, please seek medical attention in consultation with your provider.
– We are recommending but not requiring that all registrants in attendance wear CDC-recommended masks.
SRNA will have masks available.
– We recommend testing before you leave home and doing all you can to minimize exposure to COVID.
Please be advised, COVID-19 risks will not be completely eliminated. Even with every intention to minimize risks, SRNA realizes that every attendee must balance these issues and make their own decision regarding risks. While there is no way to guarantee a COVID-free environment, SRNA is exercising all reasonable precautions it can to reduce risks of COVID impact. On behalf of all in attendance, thank you for your understanding and cooperation.
SRNA 2023 education and support programs are supported by donations from our community and in part through grants from
Horizon is focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. They apply scientific expertise and courage to bring clinically meaningful therapies to patients. Horizon believes science and compassion must work together to transform lives.
Alexion is a global biopharmaceutical company focused on serving patients with severe and rare disorders through the innovation, development and commercialization of life-transforming therapeutic products. Their goal is to deliver medical breakthroughs where none currently exist, and they are committed to ensuring that patient perspective and community engagement is always at the forefront of their work.
Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit https://www.gene.com.
* All educational content and programs are solely developed by the SRNA staff, members of the scientific board and approved by Board of Directors.
